Product image of Linezolida Mylan (Linezolid) supplied by GNH India

Linezolida Mylan

Active Ingredient:
Linezolid
Origin:
EU

Linezolida Mylan (Linezolid)

Linezolid, the active ingredient in Linezolida Mylan, is an oxazolidinone antibiotic presented as an oral dosage form for oral use. It treats skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, and other complicated infections caused by Gram‑positive bacteria such as MRSA and VRE.\n\nGNH India supplies Linezolida Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Linezolid is indicated for infections caused by Gram‑positive bacteria, particularly when other agents are unsuitable.\n\nSkin and soft tissue infections: effective against MRSA and other Gram‑positive pathogens, reducing infection severity.\nCommunity‑acquired pneumonia: provides coverage for typical and atypical Gram‑positive organisms.\nNosocomial pneumonia: active against resistant Gram‑positive strains in hospital settings.\nComplicated Gram‑positive infections: treats infections such as bacteremia or endocarditis caused by VRE or other resistant organisms.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks the translation process, halting bacterial growth and leading to a bacteriostatic effect against susceptible Gram‑positive organisms.

Side Effects

  • Linezolid may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Nausea\n- Diarrhea\n- Headache\n- Metallic taste\n- Vomiting\n- Rash\n\nSerious or Rare Side Effects:\n- Thrombocytopenia or other blood dyscrasias\n- Peripheral neuropathy, especially with prolonged use\n- Serotonin syndrome when combined with serotonergic agents\n- Lactic acidosis\n- Optic neuropathy\n- Myelosuppression

Precautions & Warnings

  • Before initiating therapy, clinicians should assess patient‑specific factors and monitor for adverse events.\n\nRenal impairment: adjust monitoring of blood counts and renal function.\nHepatic impairment: use with caution and monitor liver enzymes.\nSerotonergic agents: avoid concomitant use due to risk of serotonin syndrome.\nLong‑term therapy: regularly assess complete blood count for hematologic toxicity.\nPregnancy and lactation: safety unknown; prescribe only if benefit outweighs potential risk.\nStore at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

  • Linezolid interacts with several drug classes; awareness helps prevent adverse outcomes.\n\nMajor Interactions (Avoid):\n- Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic drugs: risk of serotonin syndrome.\n- Monoamine oxidase inhibitors (MAOIs): increased serotonin toxicity.\n- Rifampicin: markedly reduces linezolid plasma concentrations.\n\nModerate Interactions (Monitor Closely):\n- Warfarin: may potentiate anticoagulant effect, monitor INR.\n- Phenytoin: may lower linezolid levels, consider therapeutic monitoring.\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased bleeding risk, observe for gastrointestinal symptoms.

Frequently Asked Questions

Linezolida Mylan contains linezolid, an oxazolidinone antibiotic indicated for skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, and other serious infections caused by Gram‑positive bacteria such as methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE).

Linezolid binds to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth, producing a bacteriostatic effect against susceptible Gram‑positive organisms.

The exact dose of Linezolida Mylan is determined by the prescribing clinician based on the infection type, severity, renal and hepatic function, and patient characteristics. Healthcare professionals follow approved dosing guidelines and adjust as needed.

Safety data for linezolid in pregnancy and lactation are limited. It is classified as pregnancy category unknown, and use is recommended only when the potential benefit justifies any potential risk to the fetus or infant. Breastfeeding mothers should consult their physician.

To order Linezolida Mylan, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Linezolid offers oral bioavailability comparable to intravenous administration, making it convenient for step‑down therapy. Unlike vancomycin, it does not require therapeutic drug monitoring for most patients and is active against many vancomycin‑resistant strains. However, cost and the potential for hematologic toxicity may influence the choice of therapy.

Store Linezolida Mylan at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, excessive heat and direct sunlight. Keep out of reach of children and ensure the packaging remains intact until use.

Linezolida Mylan is administered orally. The tablet (or oral formulation) should be swallowed whole with a glass of water. It can be taken with or without food, but patients should follow any specific instructions provided by their healthcare professional.

Serious risks include thrombocytopenia or other blood dyscrasias, peripheral neuropathy (especially with prolonged therapy), serotonin syndrome when combined with serotonergic drugs, lactic acidosis, optic neuropathy, and myelosuppression. Patients should report unusual bleeding, vision changes, numbness, or mood alterations promptly.

Linezolida Mylan should be avoided in individuals with known hypersensitivity to linezolid or any oxazolidinone. It is also contraindicated in patients currently receiving monoamine oxidase inhibitors (MAOIs) and should be used with caution in those on serotonergic agents due to the risk of serotonin syndrome.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT